🔬 Science 9h ago

Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans

Medical Xpress
Medical Xpress health science
View Channel →
Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans
Source ↗ 👁 0 💬 0
The current Bundibugyo Ebola virus (BDBV) outbreak in the Democratic Republic of the Congo is the second largest Ebola outbreak worldwide, with over 6,000 confirmed cases and a 48% fatality rate. There is currently no approved BDBV vaccine.

Comments (0)

Sign in to join the discussion

More Like This

Ascension Island: How a planting project created a lush cloud forest
Phys.org - latest science and technology news stories · 1h ago
Parents of kids who need complex medical care at home tend to resolve frequent safety issues on their own, study finds
Medical Xpress - latest medical and health news stories · 4h ago
Watch SpaceX deliver more than 6,000 pounds of cargo to the ISS today
Latest from Space.com · 4h ago
Lasers and Doppler effect could personalize chemotherapy drug selection for cancer tumors
Medical Xpress - latest medical and health news stories · 4h ago
Consumers need clearer answers before they can trust precision fermentation, new report finds
Phys.org - latest science and technology news stories · 4h ago
Advanced MRI data set maps adolescent brain development
Medical Xpress - latest medical and health news stories · 5h ago